Forlenza does research with Medtronic and Dexcom, which both manufacture blood glucose monitoring systems. “The idea that young adults would be taking pictures of their own sensor array in school or ...

AI-enhanced glucose monitoring provides predictive analytics and personalized insights for better blood sugar management.

Medtronic (NYSE:MDT) today announced real-world data supporting the use of its smart insulin pen and CGM sensor combination.

Continuous glucose monitors overestimated blood sugar levels in non-diabetic people in a small study. More health-conscious people are wearing the devices that were FDA-approved for over-the ...

The company’s blood oxygen management ... base and strengthened its continuous glucose monitor (CGM) attachment rates, as per the earnings release. Medtronic has not changed its fiscal year ...